Article
Paradoxical enhancement of interleukin-2-mediated cytotoxicity against K562 cells by addition of a low dose of methotrexate.
Cancer immunology, immunotherapy : CII - 1 Jan 1990
Nakarai T, Ueno Y, Ueno Y, Koizumi S
Abstract excerpt
In vitro effects of methotrexate (MTX) on interleukin-2(IL-2)-mediated cytotoxicity of peripheral blood mononuclear cells (PBMC) were studied. PBMC were incubated with human recombinant IL-2 (25 U/ml) for 72 h; during the last 24 h, various concentrations (10 pM-1 microM) of MTX were added to the culture. Cytotoxicity against k562 cells was measured by a 4-h 51Cr-release assay. The IL-2-mediated cytotoxicity was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
